Evolving molecular-based targeted therapy for cancer: An exciting field

Benedito Carneiro; Katy Hsiao; Janardan Khandekar

doi:10.1385/COMP:31:4:299

Evolving molecular-based targeted therapy for cancer: An exciting field

Benedito Carneiro, Katy Hsiao, Janardan Khandekar^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Review article › peer-review

Abstract

The development of molecular biology tools has led to the identification of numerous therapeutic targets in cancer cells. In this article, we discuss the rational and clinical data supporting the use of agents that selectively target epidermal and vascular endothelial growth factors in selected cancers.

Original language	English (US)
Pages (from-to)	299-305
Number of pages	7
Journal	Comprehensive therapy
Volume	31
Issue number	4
DOIs	https://doi.org/10.1385/COMP:31:4:299
State	Published - Dec 2005

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1385/COMP:31:4:299

Cite this

@article{376210eb03b54865adc9547bc087061a,

title = "Evolving molecular-based targeted therapy for cancer: An exciting field",

abstract = "The development of molecular biology tools has led to the identification of numerous therapeutic targets in cancer cells. In this article, we discuss the rational and clinical data supporting the use of agents that selectively target epidermal and vascular endothelial growth factors in selected cancers.",

author = "Benedito Carneiro and Katy Hsiao and Janardan Khandekar",

year = "2005",

month = dec,

doi = "10.1385/COMP:31:4:299",

language = "English (US)",

volume = "31",

pages = "299--305",

journal = "Comprehensive therapy",

issn = "0098-8243",

publisher = "Humana Press",

number = "4",

}

TY - JOUR

T1 - Evolving molecular-based targeted therapy for cancer

T2 - An exciting field

AU - Carneiro, Benedito

AU - Hsiao, Katy

AU - Khandekar, Janardan

PY - 2005/12

Y1 - 2005/12

N2 - The development of molecular biology tools has led to the identification of numerous therapeutic targets in cancer cells. In this article, we discuss the rational and clinical data supporting the use of agents that selectively target epidermal and vascular endothelial growth factors in selected cancers.

AB - The development of molecular biology tools has led to the identification of numerous therapeutic targets in cancer cells. In this article, we discuss the rational and clinical data supporting the use of agents that selectively target epidermal and vascular endothelial growth factors in selected cancers.

UR - http://www.scopus.com/inward/record.url?scp=30444445544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30444445544&partnerID=8YFLogxK

U2 - 10.1385/COMP:31:4:299

DO - 10.1385/COMP:31:4:299

M3 - Review article

C2 - 16407611

AN - SCOPUS:30444445544

SN - 0098-8243

VL - 31

SP - 299

EP - 305

JO - Comprehensive therapy

JF - Comprehensive therapy

IS - 4

ER -

Evolving molecular-based targeted therapy for cancer: An exciting field

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this